DOES THE BENEFIT OF ADJUVANT RADIOTHERAPY FOLLOWING RADICAL PROSTATECTOMY FOR PATHOLOGIC T3 OR MARGIN-POSITIVE PROSTATE CANCER EXTEND TO ALL PATHOLOGIC SUBGROUPS? A META-ANALYSIS OF THE RANDOMIZED TRIALS

被引：0
|
作者：
Morgan, S. [1 ]
Walker-Dilks, C. [2 ]
Goldman, B. [3 ]
Eapen, L. [1 ]
Winquist, E. [4 ]
Chin, J. [4 ]
Swanson, G. [5 ]
Thompson, I. [5 ]
Loblaw, A. [6 ]
机构：
[1] Univ Ottawa, Ottawa, ON, Canada
[2] McMaster Univ, Hamilton, ON, Canada
[3] Southwest Oncol Grp Stat Ctr, Seattle, WA USA
[4] Univ Western Ontario, London, ON, Canada
[5] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA
[6] Univ Toronto, Toronto, ON, Canada
来源：
RADIOTHERAPY AND ONCOLOGY | 2010年 / 96卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
25
引用
收藏
页码：S8 / S9
页数：2
相关论文
共 18 条
  • [1] Does the Benefit of Adjuvant Radiotherapy following Radical Prostatectomy for Pathologic T3 or Margin-positive Prostate Cancer Extend to All Pathologic Subgroups? A Meta-analysis of the Randomized Trials
    Morgan, S. C.
    Walker-Dilks, C.
    Goldman, B.
    Eapen, L. J.
    Winquist, E. W.
    Chin, J. L.
    Swanson, G. P.
    Thompson, I. M.
    Loblaw, D. A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S29 - S30
  • [2] Adjuvant radiotherapy following radical prostatectomy for pathologic T3 or margin-positive prostate cancer: A systematic review and meta-analysis
    Morgan, Scott C.
    Waldron, Tricia S.
    Eapen, Libni
    Mayhew, Linda A.
    Winquist, Eric
    Lukka, Himu
    RADIOTHERAPY AND ONCOLOGY, 2008, 88 (01) : 1 - 9
  • [3] Adjuvant Radiation Therapy Following Radical Prostatectomy for Pathologic T3 or Margin-positive Prostate Cancer: Are the EAU Guidelines Correct?
    Kamphuis, Guido M.
    Sodha, Hiren S.
    de Reijke, Theo M.
    EUROPEAN UROLOGY SUPPLEMENTS, 2011, 10 (03) : E44 - E48
  • [4] Adjuvant radiotherapy versus wait-and-see strategy for pathologic T3 or margin-positive prostate cancer: A meta-analysis
    Shaikh, Mohammad Parvez
    Harkenrider, Matthew M.
    Wu, Meng-Jia
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07)
  • [5] Adjuvant Radiotherapy Versus Wait-and-See Strategy for Pathologic T3 or Margin-Positive Prostate Cancer A Meta- Analysis
    Shaikh, M. Parvez
    Alite, Fiori
    Wu, Meng-Jia
    Solanki, Abhishek A.
    Harkenrider, Matthew M.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2018, 41 (08): : 730 - 738
  • [6] Positive Surgical Margin Trends in Patients with Pathologic T3 Prostate Cancer Treated with Robot-Assisted Radical Prostatectomy
    Lightfoot, Andrew J.
    Su, Yu-Kai
    Sehgal, Shailen S.
    Lee, Ziho
    Greaves, Giovanni H.
    Yu, Sue-Jean S.
    Llukani, Elton
    Su, Yu-Chen
    Lee, David I.
    JOURNAL OF ENDOUROLOGY, 2015, 29 (06) : 634 - 639
  • [7] Adjuvant radiotherapy following radical prostatectomy for prostate cancer: A systematic review and meta-analysis
    Ayer Botrel, Tobias Engel
    Clark, Otavio
    Horta Bretas, Francisco Flavio
    Sadi, Marcus V.
    Ferreira, Ubirajara
    Paladini, Luciano
    Matheus, Wagner Eduardo
    Reis, Rodolfo
    Duraes, Ronilson Oliveira
    Lima Pompeu, Antonio Carlos
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [8] Positive resection margin and/or pathologic T3 adenocarcinoma of prostate with undetectable postoperative prostate-specific antigen after radical prostatectomy: To irradiate or not?
    Choo, R
    Hruby, G
    Hong, J
    Hong, E
    DeBoer, G
    Danjoux, C
    Morton, G
    Klotz, L
    Bhak, E
    Flavin, A
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2002, 52 (03): : 674 - 680
  • [9] Timing and patterns of recurrences and deaths from prostate cancer following adjuvant pelvic radiotherapy for pathologic stage T3/4 adenocarcinoma of the prostate
    Anscher, M. S.
    Clough, R.
    Robertson, C. N.
    Prosnitz, L. R.
    Dahm, P.
    Walther, P.
    Donatucci, C. F.
    Albala, D. M.
    Febbo, P.
    George, D. J.
    Sun, L.
    Moul, J. W.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2006, 9 (03) : 254 - 260
  • [10] Timing and patterns of recurrences and deaths from prostate cancer following adjuvant pelvic radiotherapy for pathologic stage T3/4 adenocarcinoma of the prostate
    M S Anscher
    R Clough
    C N Robertson
    L R Prosnitz
    P Dahm
    P Walther
    C F Donatucci
    D M Albala
    P Febbo
    D J George
    L Sun
    J W Moul
    Prostate Cancer and Prostatic Diseases, 2006, 9 : 254 - 260
12